These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2952500)

  • 21. Interpretive criteria of ceftibuten disk diffusion susceptibility tests according to the DIN 58 940 method.
    Kleinkauf N; Rodloff AC
    Clin Microbiol Infect; 2001 Jun; 7(6):326-30. PubMed ID: 11442566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Josamycin: interpretation of inhibition zones with the Bauer-Kirby agar disk diffusion test as compared with erythromycin.
    Karthein J; Spohr M; Traub WH
    Chemotherapy; 1986; 32(4):336-43. PubMed ID: 3731919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calibration of the disk diffusion test for trovafloxacin susceptibility testing of four anaerobic species.
    Kronvall G; Holst E
    Clin Microbiol Infect; 2000 Apr; 6(4):195-201. PubMed ID: 11168107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-vitro activity of dirithromycin in comparison with other new and established macrolides.
    Bauernfeind A
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():39-49. PubMed ID: 8478311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [In vitro activity of roxithromycin against hospital bacteria and the concordance curve].
    Soussy CJ; Chanal M; Kitzis MD; Duval J; Cluzel R; Acar JF
    Pathol Biol (Paris); 1988 May; 36(5):420-4. PubMed ID: 2900488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interpretive standards for disk susceptibility tests with Sch 21420 and amikacin.
    Barry AL; Thornsberry C; Jones RN; Gerlach EH
    Antimicrob Agents Chemother; 1980 Oct; 18(4):616-21. PubMed ID: 7447420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tentative disk diffusion susceptibility interpretive criteria for pefloxacin.
    Fuchs PC; Barry AL; Jones RN; Thornsberry C
    J Clin Microbiol; 1986 Sep; 24(3):448-50. PubMed ID: 3463566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative in vitro activity of A-56268.
    Sefton AM; Maskell JP; Yong FJ; Chi SJ; Williams JD
    Eur J Clin Microbiol Infect Dis; 1988 Dec; 7(6):798-802. PubMed ID: 2975218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detecting erythromycin resistance in Streptococcus pyogenes: reliability of the disk diffusion method and the breakpoint susceptibility testing method. Finnish Study Group for Antimicrobial Resistance (FIRE).
    Nissinen A; Seppälä H; Huovinen P
    Scand J Infect Dis; 1995; 27(1):52-6. PubMed ID: 7784814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial activity of erythromycin and clarithromycin against clinical isolates of Escherichia coli, Staphylococcus aureus, Klebsiella and Proteus by disc diffusion method.
    Khan NW; Hassan F; Naqvi BS; Hasan SM
    Pak J Pharm Sci; 2011 Jan; 24(1):25-9. PubMed ID: 21190914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial resistance testing of Helicobacter pylori: a comparison of Etest and disk diffusion methods.
    Midolo PD; Bell JM; Lambert JR; Turnidge JD; Grayson ML
    Pathology; 1997 Nov; 29(4):411-4. PubMed ID: 9423225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of NCCLS macrolide (azithromycin, clarithromycin, and erythromycin) interpretive criteria for Haemophilus influenzae tested with the Haemophilus test medium. National Committee for Clinical Laboratory Standards.
    Jones RN; Doern GV; Gerlach EH; Hindler J; Erwin ME
    Diagn Microbiol Infect Dis; 1994 Apr; 18(4):243-9. PubMed ID: 7924221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testing for induction of clindamycin resistance in erythromycin-resistant isolates of Staphylococcus aureus.
    Steward CD; Raney PM; Morrell AK; Williams PP; McDougal LK; Jevitt L; McGowan JE; Tenover FC
    J Clin Microbiol; 2005 Apr; 43(4):1716-21. PubMed ID: 15814990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of in vitro antimicrobial activity of cefazolin alone and in combination with cefmetazole or flomoxef using agar dilution method and disk diffusion method].
    Matsuo K; Uete T
    Jpn J Antibiot; 1992 Oct; 45(10):1253-66. PubMed ID: 1479676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of ABT-773 versus macrolides and quinolones against resistant respiratory tract pathogens.
    Dubois J; St -Pierre C
    Diagn Microbiol Infect Dis; 2001; 40(1-2):35-40. PubMed ID: 11448561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interpretive criteria for temocillin disk diffusion susceptibility testing.
    Fuchs PC; Barry AL; Thornsberry C; Jones RN
    Eur J Clin Microbiol; 1985 Feb; 4(1):30-3. PubMed ID: 3872793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxyrase, a method which avoids CO2 in the incubation atmosphere for anaerobic susceptibility testing of antibiotics affected by CO2.
    Spangler SK; Appelbaum PC
    J Clin Microbiol; 1993 Feb; 31(2):460-2. PubMed ID: 8381817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of new macrolides against Bordetella pertussis and Bordetella parapertussis.
    Hoppe JE; Eichhorn A
    Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):653-4. PubMed ID: 2550234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative in vitro activity of A-56268 (TE-031), a new macrolide antibiotic.
    Hodinka RL; Jack-Wait K; Gilligan PH
    Eur J Clin Microbiol; 1987 Feb; 6(1):103-8. PubMed ID: 2952499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (Ro 15-8074) and cefteram (Ro 19-5247) disk tests.
    Jones RN; Barry AL
    J Clin Microbiol; 1987 Sep; 25(9):1796-9. PubMed ID: 3654953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.